Virus-specific T cells - effectiveness, safety profile and use
Clinical trials of immune checkpoint inhibitors in acute myeloid leukemia (AML)
Naval G. Daver
New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics
Understanding the drivers behind disease with the 100,000 Genomes Project
Where will leukemia research go next?